Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.1 (
asparaginase
)
2,695
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Homogenous deamidase AG from Pseudomonas fluorescens AG was found to be a
glycoprotein
with molecular weight of about 13,000 daltons. The molecule consists apparently of four similar or identic subunits with molecular weight of about 30,000 daltons. The amino acid composition, N-terminal amino acids, the amount of chymotryptic peptides, containing 14C-carboxymethyl cysteine were studied. The enzyme exhibited distinct antitumoral effect on cells of Burkitt's lymphoma, sensitive to
asparaginase
, but did not exhibit marked cytotoxic action on cells of human ovarium cancer CaOV line, resistant to asparaginases.
...
PMID:[Physico-chemical properties of deamidase AG from Pseudomonas fluorescens AG possessing antitumor activity]. 41 Dec 53
Desialised orosomucoid (alpha-1-acidic
glycoprotein
) was coupled to Pseudomonas 7A glutaminase-
asparaginase
by glutaraldehyde, iodinated and injected into mice. The half-life of radioactivity and glutaminase activity in plasma was about 7 min. Radioactivity and glutaminase activity in the liver reached a peak at about 20 min. The radioactivity in liver then declined with a half-life of about 20 min. Enzyme activity in liver declined with a half-life of about 10 min. The ratio of enzyme activity to radioactivity was lower in the liver than in plasma at all times during the experiment, indicating rapid hepatic inactivation of the enzyme. Uptake into the liver could be blocked by excess desialised orosomucoid. Glutamine levels in the liver were about 10% of normal for 44 min but returned to 50% of normal by 93 min. Intestines, kidney and spleen failed to exhibit any appreciable uptake of desialated orosomucoid glutaminase-
asparaginase
.
...
PMID:Kinetics of uptake and activity in mouse liver of glutaminase coupled to desialated orosomucoid. 62 51
A human renal carcinoma cell line (Caki-1) was examined for asparagine (Asn) dependence and susceptibility to Escherichia coli
asparaginase
. Because this enzyme hydrolyzes glutamine (Gln) as well as Asn, even though at only 2-3% the rate, Asn- Gln+ and Asn- Gln- media were prepared. Only the former supported Caki growth. The Asn- Gln- medium was then repleted with Asn, Gln, or both. Although Asn repletion failed to promote growth, addition of Gln alone or the combination supported growth as well as complete medium. With [3H]leucine and [3H]mannose incorporation to indicate protein and
glycoprotein
synthesis, respectively, the Gln repleted medium supported these processes as well as complete medium. Asparaginase added to complete medium was highly toxic to the Caki cells, but this is a reflection of Gln depletion rather than Asn depletion.
...
PMID:Human renal carcinoma: asparagine independence with asparaginase susceptibility in culture. 290 36
Asparaginase II of Saccharomyces cerevisiae is a cell wall mannan containing
glycoprotein
. Recent studies have demonstrated that
asparaginase II
activity increases in exponentially growing cell cultures and then decreases as the cells enter the stationary phase. Enzyme inactivation has been attributed to a Zn2+-dependent protease which is synthesized de novo during the late exponential phase [Pauling, K.D., & Jones, G.E. (1980) J. Gen. Microbiol. 117, 423-430; Pauling, K.D., & Jones, G.E. (1980) Biochim. Biophys. Acta 616, 271-282]. We have investigated the mechanism of
asparaginase II
inactivation using both whole cell suspensions and highly purified enzyme. Our data indicate that the rate of
asparaginase II
inactivation in cell suspensions is primarily influenced by pH changes that occur as a consequence of cell growth and glucose fermentation and that enzyme inactivation is not dependent on Zn2+ or on de novo protein synthesis. Also, in vitro studies with purified enzyme show kinetics of inactivation that are similar to those observed in vivo. Consequently, involvement of a yeast protease in the inactivation process is relatively unlikely.
...
PMID:Asparaginase II of Saccharomyces cerevisiae: comparison of enzyme stability in vivo and in vitro. 634 51
The
glycoprotein
fibronectin is, as well as by various other cells, also produced in leucocytes and is said to play an important role in malignant transformation of cells. Therefore, the behaviour of plasma fibronectin and of factor VIII R:AG was investigated in acute leukaemia in order to prove their significance as prognostic and therapeutic markers (method: electroimmunoassay). In patients with acute myeloid leukaemia (n = 29) and acute lymphoblastic leukaemia (n = 11) no significant changes in fibronectin concentration could be evaluated. Fibronectin levels declined significantly only during therapy with
asparaginase
in patients with acute lymphoblastic leukaemia, probably as a result of disturbed synthesis in the liver. Using crossed immunoelectrophoresis against fibronectin antiserum, one normal and one slower migrating antigen (FN:C) could be observed in nearly all plasma samples in patients with acute leukaemia. By means of in vitro tests with highly purified substances and intermediate gel electrophoresis it could be shown that FN:C represents fibronectin which has bound fibrinogen, probably crosslinked by activated factor XIII. Factor VIII R:AG was found to be greatly raised in patients with acute leukaemia--up to 1400% of the normal level. Increased levels correlated well with a worsening of the disease. The protein seems to be suitable for estimating the activity and prognosis of acute leukaemia.
...
PMID:Fibronectin and factor VIII-related antigen in acute leukaemia. 640 58
High concentrations of Escherichia coli
asparaginase
(80 U/ml) altered the binding of concanavalin A (Con A) to L 5178Y murine lymphoma cells that are sensitive to the cytotoxic action of this enzyme. Incubation of the
asparaginase
sensitive line in asparagine-free media or media containing Acinetobacter glutaminase-
asparaginase
did not alter the Con A binding of these cells. Escherichia coli
asparaginase
had no effect on Con A binding of two
asparaginase
resistant L5178Y cell lines that were isolated and maintained in asparagine depleted or
asparaginase
containing medium. The E. coli
asparaginase
preparation inhibited protein and
glycoprotein
biosynthesis to comparable degrees. It did not have proteolytic or glycolytic activity. Escherichia coli
asparaginase
did not alter the binding of wheat germ, soybean or ricin agglutinins to any of these cell lines. These data suggest that high concentrations of E. coli
asparaginase
have a specific effect on the Con A receptor in the sensitive line.
...
PMID:Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells. 672 17
Mouse myeloid leukemic M1 cells can be induced to differentiate into macrophages and granulocytes in vitro by a factor(s) stimulating differentiation of the cells (D-factor), which is suggested to be a
glycoprotein
. On the other hand, growth and differentiation of normal precursor cells of macrophages and granulocytes can be stimulated by a
glycoprotein
termed colony-stimulating factor (CSF). Mouse fibroblast L929 cells were found to produce both the D-factor and CSF. The properties of the D-factor and CSF and the roles of carbohydrates in the molecules of these factors were examined using tunicamycin, a specific inhibitor of
asparaginase
-linked glycosylation. Although both the D-factor and CSF were produced by L-cells in usual medium containing fetal calf serum, production of D-factor, but not CSF, was reduced by omission of serum from the medium. The activity of the D-factor was slightly decreased by treating the L-cells with tunicamycin (0.5 microgram/ml) in the presence of 2% fetal calf serum, without any decrease in CSF activity. Conditioned medium of L-cells incubated with or without tunicamycin was fractionated by gel filtration on a Sephadex G-200 column. Normal D-factor appeared as a single peak with an apparent molecular weight of 67,000. D-factor produced in the presence of tunicamycin had an apparent molecular weight of 25,000. On the other hand, most of the CSF was eluted in the void volume, even when it was produced in the presence of tunicamycin. The D-factor produced in the presence of tunicamycin was more sensitive than normal D-factor was to trypsin or heat treatment at 70 degrees. The CSF produced in the presence of tunicamycin was resistant to these treatments. These results indicate that the D-factor is distinct from CSF. Furthermore, the results suggest that the D-factor produced by L-cells is also a
glycoprotein
and that, although carbohydrate is not essential for production or activity of the D-factor, it contributes to stabilizing the protein portion of D-factor.
...
PMID:Effect of tunicamycin on production by mouse fibroblast L929 cells of the factor-stimulating differentiation of mouse myeloid leukemic cells and the colony-stimulating factor. 697 52
Detailed kinetic analysis was performed on
asparaginase II
, a cell wall
glycoprotein
from Saccharomyces cerevisiae. The enzyme was highly active in the hydrolysis and hydroxylaminolysis reactions with D- and L-asparagine and with a variety of N-substituted analogues. The data from studies involving pH dependencey, substrate saturation, and product inhibition support the hypotheses that (a) the yeast
asparaginase
mechanism proceeds via an acyl enzyme intermediate; (b) an ionizable group on the enzyme, pK approximately 6.0, is involved in the acylation and deacylation reactions; and (c) yeast
asparaginase II
is a peptidoasparaginase.
...
PMID:Reactions of asparaginase II of Saccharomyces cerevisiae. A mechanistic analysis of hydrolysis and hydroxylaminolysis. 698 75
Cultured human pancreatic carcinoma cells (MIA PaCa-2) have been shown previously to be very sensitive to E. coli
L-asparaginase
(EC II). The present studies have demonstrated that another enzyme, Acinetobacter glutaminase-
asparaginase
(
AGA
) is much more effective in inhibiting cell growth. At the concentration of 0.0025 U/ml of
AGA
activity the enzyme totally inhibited cell growth, whereas the EC II with the same concentration did not show any effect. The inhibition of cell growth correlated well with inhibition of protein and
glycoprotein
synthesis. The addition of L-glutamine at the concentration of 1 mM completely reversed the inhibition of protein synthesis. Similarly, the addition of L-glutamine at the concentration of 3 mM daily on 3 successive days after adding
AGA
resulted in significant reversal of growth inhibition. The results of this study indicate that the action of
AGA
on MIA PaCa-2 is, to a great extent, exerted through its L-glutaminase activity.
...
PMID:Sensitivity of cultured pancreatic carcinoma cells to Acinetobacter glutaminase-asparaginase. 717 49